AVX, a leading manufacturer of passive components and interconnect solutions, has released a new series of next-generation, medical-grade solid tantalum capacitors. Delivering lower DC leakage (DCL) values than any competitive offering down to 0.0025CV, or 25% of typical industry limits and requiring significantly less voltage de-rating than the standard 50% recommendation for solid tantalum capacitors as low as 20% for filtering applications, and as low as 0% for pacing, hold-up, and charging application â€” the series is ideal for use in a variety of medical implantable and life support devices.
TAZ Series HRC6000 capacitors are manufactured using AVX's patented Q-Process, which was developed to ensure the production of the highest reliability tantalum capacitors possible by replacing a portion of the Weibull Reliability Assessment as the industry standard due to its tendency to burn-in potentially unstable units. In use since 2013, the Q-Process employs enhanced embedded screening to effectively remove any component that may experience parametric shifts as a result of processing or display instability through life testing, providing customers with stable and normalized DCL distribution and unsurpassed reliability.
TAZ Series HRC6000 medical-grade, solid tantalum capacitors are currently available in E-cases (Metric Code: 5025) with three rated voltages (6V, 10V, and 15V), three capacitance tolerances (±5%, ±10%, and ±20%), and with capacitance values spanning 10µF to 33µF. Additional series introductions scheduled for later this year will include A-cases (Metric Code: 2512) with the same voltage ratings and capacitance values spanning 0.68µF to 1.5µF. Rated operating temperatures for the series range from -55°C to +125°C.
Looking for parts? Go to SourceESB.